Dr. Tatjana Kolevska, MD
Claim this profileKaiser Permanente-Vallejo
Studies Skin Cancer
Studies Cutaneous Melanoma
21 reported clinical trials
51 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
BRAF positive
2Cutaneous Melanoma
Stage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Tatjana Kolevska, MD is currently running
Cemiplimab + Palbociclib
for Liposarcoma
This phase II trial compares the effect of treatment with palbociclib alone to treatment with palbociclib plus cemiplimab for treating patients with dedifferentiated liposarcoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Palbociclib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Cemiplimab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. The combination of these two drugs may be more effective in shrinking or stabilizing advanced dedifferentiated liposarcoma compared to palbociclib alone.
Recruiting1 award Phase 2
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Tatjana Kolevska, MD
Clinical Trial Related7 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Tatjana Kolevska, MD has experience with
- Nivolumab
- Ipilimumab
- MFOLFIRINOX
- Lenalidomide
- Carboplatin
- Pembrolizumab
Breakdown of trials Tatjana Kolevska, MD has run
Skin Cancer
Cutaneous Melanoma
Melanoma
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tatjana Kolevska, MD specialize in?
Tatjana Kolevska, MD focuses on Skin Cancer and Cutaneous Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Tatjana Kolevska, MD currently recruiting for clinical trials?
Yes, Tatjana Kolevska, MD is currently recruiting for 13 clinical trials in Vallejo California. If you're interested in participating, you should apply.
Are there any treatments that Tatjana Kolevska, MD has studied deeply?
Yes, Tatjana Kolevska, MD has studied treatments such as Nivolumab, Ipilimumab, mFOLFIRINOX.
What is the best way to schedule an appointment with Tatjana Kolevska, MD?
Apply for one of the trials that Tatjana Kolevska, MD is conducting.
What is the office address of Tatjana Kolevska, MD?
The office of Tatjana Kolevska, MD is located at: Kaiser Permanente-Vallejo, Vallejo, California 94589 United States. This is the address for their practice at the Kaiser Permanente-Vallejo.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.